Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma
- 5 June 2009
- journal article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 41 (12) , 902-906
- https://doi.org/10.1016/j.dld.2009.04.013
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular CarcinomaJournal of Clinical Oncology, 2008
- Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific mannerClinical & Experimental Metastasis, 2007
- Identification and Clinical Significance of Mobilized Endothelial Progenitor Cells in Tumor Vasculogenesis of Hepatocellular CarcinomaClinical Cancer Research, 2007
- NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive ratsGut, 2007
- Significance of circulating endothelial progenitor cells in hepatocellular carcinoma†Hepatology, 2006
- Treatment and prognostic factors in patients with hepatocellular carcinomaLiver International, 2006
- Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive ratsJournal of Hepatology, 2006
- Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive ratsJournal of Hepatology, 2005
- Circulating endothelial progenitor cells in multiple myeloma: implications and significanceBlood, 2005
- Angiogenesis and hepatocellular carcinomaJournal of Hepatology, 2004